Skip to main content

Want a detailed portfolio tracker?

Verona Pharma (VRNA) Operating Margin (2021 - 2025)

Verona Pharma (VRNA) operating margin from Sep 30, 2021 to Jun 30, 2025. The current Verona Pharma (VRNA) operating margin is 12.90%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Verona Pharma (VRNA)

YearOperating MarginChange
2024-357.21%
-97.51%
2022-14373.91%
+9868.04%
2021-144.20%
N/A

Comparison Verona Pharma (VRNA) operating margin with competitors

Verona Pharma (VRNA) operating margin is 12.90%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%+3558586.46%
APLMApollomics Inc - Class A431.90%+3246.82%
ABUSArbutus Biopharma Corp94.30%+630.74%
SAVACassava Sciences Inc.93.36%+623.45%
RPRXRoyalty Pharma plc - Class A89.29%+591.91%
GLPGGalapagos NV84.24%+552.78%
NEUPNeuphoria Therapeutics Inc79.85%+518.76%
BDTXBlack Diamond Therapeutics Inc77.90%+503.65%
CTNMContineum Therapeutics Inc - Class A77.87%+503.42%
CVACCureVac N.V.74.59%+478.00%
IPSCCentury Therapeutics Inc67.95%+426.55%
FULCFulcrum Therapeutics Inc65.62%+408.49%
AVIRAtea Pharmaceuticals Inc63.06%+388.66%
PLXProtalix BioTherapeutics Inc62.65%+385.48%
PRTAProthena Corporation plc58.80%+355.64%
AUPHAurinia Pharmaceuticals Inc53.31%+313.10%
ADMAAdma Biologics Inc50.90%+294.43%
RPTXRepare Therapeutics Inc50.85%+294.04%
CRMDCorMedix Inc49.96%+287.14%
HCWBHCW Biologics Inc49.45%+283.19%
CPRXCatalyst Pharmaceuticals Inc49.02%+279.86%
SRPTSarepta Therapeutics Inc49.00%+279.70%
HALOHalozyme Therapeutics Inc48.98%+279.55%
KRYSKrystal Biotech Inc46.14%+257.54%
AGENAgenus Inc44.62%+245.76%
CGENCompugen Ltd43.05%+233.60%
SVASinovac Biotech Ltd42.30%+227.79%
EXELExelixis Inc41.15%+218.87%
QTTBQ32 Bio Inc39.80%+208.41%
INVAInnoviva Inc38.94%+201.75%
VRTXVertex Pharmaceuticals Inc38.10%+195.24%
NXTCNextcure Inc36.70%+184.39%
LGNDLigand Pharmaceuticals Inc - Class B33.58%+160.21%
SLNOSoleno Therapeutics Inc33.06%+156.18%
JAZZJazz Pharmaceuticals plc31.49%+144.02%
ARGXArgen X SE30.35%+135.18%
CAICaris Life Sciences Inc - Class A30.19%+133.94%
TNGXTango Therapeutics Inc26.15%+102.64%
GMABGenmab25.11%+94.58%
ZVRAZevra Therapeutics Inc24.40%+89.08%
TECHBio-Techne Corp24.24%+87.84%
INCYIncyte Corp23.66%+83.34%
RIGLRigel Pharmaceuticals20.21%+56.61%
ICCCImmucell Corp19.01%+47.31%
REGNRegeneron Pharmaceuticals Inc17.83%+38.17%
NERVMinerva Neurosciences Inc17.73%+37.39%
HRMYHarmony Biosciences Holdings Inc17.31%+34.14%
TGTXTG Therapeutics Inc16.98%+31.58%
BMRNBiomarin Pharmaceutical Inc16.92%+31.11%
ONCBeiGene Ltd16.51%+27.94%
PTCTPTC Therapeutics Inc16.50%+27.86%
PHARPharming Group N.V.16.26%+26.00%
ENVBEnveric Biosciences Inc13.38%+3.68%
VXRTVaxart Inc13.19%+2.21%
ALNYAlnylam Pharmaceuticals Inc12.01%-6.93%
ASNDAscendis Pharma A/S10.06%-22.04%
APLSApellis Pharmaceuticals Inc9.86%-23.59%
FOLDAmicus Therapeutics Inc8.61%-33.28%
CGEMCullinan Oncology Inc7.24%-43.90%
IMCRImmunocore Holdings plc6.82%-47.15%
NAGENiagen Bioscience Inc5.01%-61.18%
NUVBNuvation Bio Inc - Class A4.66%-63.89%
BMEABiomea Fusion Inc2.46%-80.94%
TLXTelix Pharmaceuticals Ltd1.58%-87.76%
HOTHHoth Therapeutics Inc0.17%-98.68%
BBLGBone Biologics Corp0.04%-99.69%